
Doctors in the UK are to launch a world-first clinical trial to assess whether drugs already on the market can prevent multiple sclerosis (MS) from worsening over time and even reverse the disabilities it causes. The groundbreaking Octopus trial, so named because of its various arms, will allow researchers to investigate the potential benefits of… Read more »